Keros Therapeutics Inc header image

Keros Therapeutics Inc

KROS

Equity

ISIN null / Valor 53581630

NASDAQ (2026-07-07)
USD 11.65+5.62%

Keros Therapeutics Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Keros Therapeutics Inc. is a biopharmaceutical company specializing in the development and commercialization of novel therapeutics aimed at modulating the transforming growth factor-beta (TGF-β) superfamily of proteins. These regulatory proteins play a crucial role in the growth, repair, and maintenance of blood cells and various tissues. By leveraging its deep expertise in TGF-β science, Keros Therapeutics aims to create innovative treatments that offer potentially disease-modifying benefits for patients with unmet medical needs. The company's focus on TGF-β signaling positions it at the forefront of developing targeted therapies that could significantly impact patient care in areas where current treatment options are limited.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-13.1%1Y
-70.1%3Y
-71.1%5Y

Performance

47.7%1Y
93.1%3Y
83.5%5Y

Volatility

Market cap

231 M

Market cap (USD)

Daily traded volume (Shares)

269,233

Daily traded volume (Shares)

1 day high/low

16.45 / 15.51

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

N-able Inc
N-able Inc N-able Inc Valor: 112382956
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.79%USD 4.38
United Therapeutics Corp
United Therapeutics Corp United Therapeutics Corp Valor: 848383
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.01%USD 563.70
Sanmina Corp
Sanmina Corp Sanmina Corp Valor: 19981543
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.45%USD 205.75
Coforge Limited
Coforge Limited Coforge Limited Valor: 144867664
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.44%INR 1,517.45
Firstsource Solutions Limited
Firstsource Solutions Limited Firstsource Solutions Limited Valor: 2909818
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.09%INR 243.95
Avery Dennison Corp
Avery Dennison Corp Avery Dennison Corp Valor: 910162
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.02%USD 164.35
Lem Holding SA
Lem Holding SA Lem Holding SA Valor: 2242762
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.17%CHF 413.00
Comet Holding Ltd.
Comet Holding Ltd. Comet Holding Ltd. Valor: 36082699
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-7.51%CHF 357.00
V-ZUG Holding Ltd
V-ZUG Holding Ltd V-ZUG Holding Ltd Valor: 54248374
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.74%CHF 40.95
argenx SE
argenx SE argenx SE Valor: 24766616
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.10%EUR 812.20